TC
MBII

TFS Capital’s Marrone Bio Innovations, Inc. MBII Stock Holding History

TFS Capital’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-157,947
Closed -$420K – 1208
2014
Q3 		$420K Buy
+157,947
New +$1.06M 0.04% 649

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

TFS Capital's MBII Position: Q4 2014 in Review

TFS Capital sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2014, closing a stake of 157,947 shares — an estimated $420K sold.

TFS Capital first reported a position in MBII in Q3 2014 and held it in 1 quarter. The position peaked at $420K in Q3 2014. 37 funds tracked by Wall St. Rank hold MBII as of Q4 2014.

  • TFS Capital reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2014 after selling out during the quarter.
  • TFS Capital sold 157,947 Marrone Bio Innovations, Inc. shares in Q4 2014, an estimated $420K.
  • TFS Capital first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 1 quarter.
  • TFS Capital's Marrone Bio Innovations, Inc. position peaked at $420K in Q3 2014.
  • 37 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2014.

Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.